Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Therapy in Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05645094
What this trial is testing

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaMSI-High
Fudan University 38
Not applicableUnknownNCT04273477
What this trial is testing

Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Testing effectiveness (Phase 2)UnknownNCT03093129
What this trial is testing

Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer (NeoART-V)

Who this might be right for
Colorectal Cancer
The 108 Military Central Hospital 200
Testing effectiveness (Phase 2)Study completedNCT02437656
What this trial is testing

Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer.

Who this might be right for
Rectal Cancer
Centre Oscar Lambret 60
Large-scale testing (Phase 3)Looking for participantsNCT06762405
What this trial is testing

PRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsatellite Unstable or Mismatch Repair-deficient Locally Advanced Rectal Cancer Patients

Who this might be right for
Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)
Centre Hospitalier Universitaire Dijon 68
Large-scale testing (Phase 3)Not Yet RecruitingNCT07074353
What this trial is testing

Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Zhejiang Cancer Hospital 360
Large-scale testing (Phase 3)Active Not RecruitingNCT06246344
What this trial is testing

Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Shandong Cancer Hospital and Institute 128
Large-scale testing (Phase 3)UnknownNCT01515787
What this trial is testing

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 1,194
Very early researchActive Not RecruitingNCT06853769
What this trial is testing

Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 48
Not applicableLooking for participantsNCT05772481
What this trial is testing

Interest of PET-MRI in the Evaluation of the Response After Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Who this might be right for
Rectal Cancer
Centre Paul Strauss 50
Not applicableNot Yet RecruitingNCT07404228
What this trial is testing

Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment

Who this might be right for
Rectal CancerChemoradiotherapyMri
Institut du Cancer de Montpellier - Val d'Aurelle 115
Testing effectiveness (Phase 2)UnknownNCT00557713
What this trial is testing

XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Who this might be right for
Rectal NeoplasmsLocally Advanced Rectal Adenocarcinoma
Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials 44
Not applicableLooking for participantsNCT06613165
What this trial is testing

Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer

Who this might be right for
Immune-related Adverse EventNeoadjuvant TherapydMMR Colorectal Cancer
Xijing Hospital 100
Testing effectiveness (Phase 2)UnknownNCT04293419
What this trial is testing

Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 58
Testing effectiveness (Phase 2)Looking for participantsNCT07622771
What this trial is testing

Neoadjuvant Radiotherapy Combined With NALIRIFOX and Adebrelimab in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Randomized, Phase II Clinical Trial

Who this might be right for
Rectal Cancers
Sun Yat-sen University 84
Testing effectiveness (Phase 2)Study completedNCT03698461
What this trial is testing

Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab

Who this might be right for
Colorectal NeoplasmsNeoplasm MetastasisColonic Neoplasms+1 more
Asan Medical Center 20
Not applicableUnknownNCT05286086
What this trial is testing

Prehabilitation in Rectal Cancer: During Neoadjuvant Therapy vs Preoperative

Who this might be right for
Rectal Cancer, AdenocarcinomaChemoradiotherapy
Corporacion Parc Tauli 50
Testing effectiveness (Phase 2)Study completedNCT01507103
What this trial is testing

Tecemotide (L-BLP25) in Rectal Cancer

Who this might be right for
Rectal Cancer
Merck KGaA, Darmstadt, Germany 124
Testing effectiveness (Phase 2)Study completedNCT00153998
What this trial is testing

Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)

Who this might be right for
Colorectal CancerLiver Metastases
Technische Universität Dresden 135
Not applicableUnknownNCT03550001
What this trial is testing

Carbon Nanoparticles as Lymph Node Tracer in Rectal Cancer After Neoadjuvant Radiochemotherapy

Who this might be right for
Rectal Cancer
YE Yingjiang 252
Next Page